Multiple personality disorder

Summary

Multiple personality disorder (MONDO:0001159) is a disease and 4 clinical trials. A subtype of dissociative disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 4

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	multiple personality disorder
Mondo ID	MONDO:0001159
MeSH	D009105
DOID	DOID:10934
ICD-10-CM	F44.81
ICD-11	1829103493
NCIT	C94330
SNOMED CT	31611000
UMLS	C0026773
MedGen	44520
Is cancer (heuristic)	no

Also known as: dissociative identity disorder

Disease family

This is a subtype of dissociative disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › dissociative disorder › multiple personality disorder

Related subtypes (2): dissociative amnesia, depersonalization disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 4.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	4

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02757339	Not specified	ENROLLING_BY_INVITATION	Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
NCT02450617	Not specified	COMPLETED	Stabilizing Group Treatment of Complex Trauma: A Randomized Controlled Trial
NCT02459340	Not specified	COMPLETED	Emotional and Cognitive Self-regulation, an EEG Study
NCT07432646	Not specified	COMPLETED	Finding Solid Ground in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study